Insider Transactions in Q4 2021 at Harvard Bioscience Inc (HBIO)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2021
|
Michael A. Rossi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,926
-1.51%
|
$48,482
$7.27 P/Share
|
|
Dec 29
2021
|
James W Green Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
52,970
-1.28%
|
$370,790
$7.27 P/Share
|
|
Dec 29
2021
|
Kenneth Fletcher Olson Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,159
-1.92%
|
$43,113
$7.27 P/Share
|
|
Dec 28
2021
|
Katherine A. Eade Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,401
+0.7%
|
-
|
|
Dec 28
2021
|
Alan I Edrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,401
+1.05%
|
-
|
|
Dec 28
2021
|
Thomas W Loewald Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,401
+0.76%
|
-
|
|
Dec 28
2021
|
Bertrand Loy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,401
+0.48%
|
-
|
|
Nov 12
2021
|
James W Green Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
13,777
-0.66%
|
-
|
|
Nov 01
2021
|
Kenneth Fletcher Olson Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,539
-0.94%
|
$10,773
$7.37 P/Share
|